Latest Breaking News On - Eczema phase - Page 1 : comparemela.com

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments ACCESSWIRE Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced an update on its clinical pipeline of CBD-based therapeutic topical formulations including JW-100 for the treatment of eczema, JW-200 for skin cancer, JW-300 for burns, and JW-400 for herpes cold sores. Commenced Patient Enrollment for Skin Cancer: Study Completion Expected Q4 2021 Jupiter s JW-200 is designed to provide action and relief in the treatment of Actinic Keratosis (AK), the most common precancer that forms on skin as a result of exposure to ultraviolet (UV) rays. The objective of this double blinded, placebo-controlled study is to evaluate the efficacy of JW-200 in both the treatment and prevention of disease, with a primary efficacy endpoint of the perc

United statesBrian johnIndications in clinical developmentSkin cancer foundationCompany investigational new drugJupiter wellness incDrug administrationFour indicationsClinical developmentJupiter wellnessPatient enrollmentSkin cancerActinic keratosisRecruitment startedFirst degree burnsEczema phase